NCT01092988View on ClinicalTrials.gov

A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Uterine FibroidsBleedingPain
Interventions
DEVICE

Exablate 2100

MR guided focused ultrasound

Trial Locations (4)

37044

Radiopharmaceutiques hopital Bretonneau, Tours

52621

Sheba MC, Ramat Gan

Unknown

Research Centre of Obstetric / Gynaecology & Perinatology, Moscow

W2 1NY

St. Mary's Hospital, London

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY

NCT01092988 - A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids | Biotech Hunter | Biotech Hunter